The first in-person use of the Crispr-Cas9 DNA editing tool is conducted, intended to reverse a genetic mutation causing Leber congenital amaurosis, a form of inherited blindness.
The first in-person use of the CRISPR-Cas9 genome editing tool is conducted, intended to reverse a genetic mutation causing Leber congenital amaurosis, a form of inherited blindness.